India
· Delayed Price · Currency is INR Camlin Fine Sciences Statistics
Total Valuation
Camlin Fine Sciences has a market cap or net worth of INR 17.83 billion. The enterprise value is 23.78 billion.
| Market Cap | 17.83B |
| Enterprise Value | 23.78B |
Important Dates
The next estimated earnings date is Tuesday, November 5, 2024.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Camlin Fine Sciences has 167.50 million shares outstanding. The number of shares has decreased by -6.31% in one year.
| Shares Outstanding | 167.50M |
| Shares Change (YoY) | -6.31% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 20.38% |
| Owned by Institutions (%) | 6.00% |
| Float | 80.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 30.20 |
| PS Ratio | 1.12 |
| PB Ratio | 2.06 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -16.72 |
| EV / Sales | 1.50 |
| EV / EBITDA | 24.25 |
| EV / EBIT | 137.40 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 79.70 |
| Debt / EBITDA | 6.97 |
| Debt / FCF | n/a |
| Interest Coverage | 0.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 0.68% |
| Revenue Per Employee | 25.47M |
| Profits Per Employee | -2.28M |
| Employee Count | 624 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.12% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -39.12% |
| 50-Day Moving Average | 108.46 |
| 200-Day Moving Average | 113.71 |
| Relative Strength Index (RSI) | 49.78 |
| Average Volume (20 Days) | 85,033 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Camlin Fine Sciences had revenue of INR 15.89 billion and -1.42 billion in losses. Loss per share was -8.49.
| Revenue | 15.89B |
| Gross Profit | 6.35B |
| Operating Income | 173.07M |
| Pretax Income | -1.39B |
| Net Income | -1.42B |
| EBITDA | 885.91M |
| EBIT | 173.07M |
| Loss Per Share | -8.49 |
Balance Sheet
The company has 802.55 million in cash and 6.83 billion in debt, giving a net cash position of -6.03 billion or -35.99 per share.
| Cash & Cash Equivalents | 802.55M |
| Total Debt | 6.83B |
| Net Cash | -6.03B |
| Net Cash Per Share | -35.99 |
| Equity (Book Value) | 8.57B |
| Book Value Per Share | 51.64 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 39.96%, with operating and profit margins of 1.09% and -8.95%.
| Gross Margin | 39.96% |
| Operating Margin | 1.09% |
| Pretax Margin | -8.73% |
| Profit Margin | -8.95% |
| EBITDA Margin | 5.57% |
| EBIT Margin | 1.09% |
| FCF Margin | n/a |
Dividends & Yields
Camlin Fine Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.31% |
| Shareholder Yield | 6.31% |
| Earnings Yield | -7.98% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 4, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Sep 4, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |